Advances in Cardiovascular Science: From Discovery to Translation

Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Basic Cardiovascular Sciences (BCVS) Scientific Sessions 2024,held from 22nd to 25th July in Chicago, Illinois.

This event features cutting-edge research and advancements in cardiovascular science, including topics like cardiac gene and cell therapy, tissue engineering, and cardiac metabolism.

Attendees will include basic cardiovascular scientists, molecular and cellular biologists, translational investigators, clinical trialists, and practicing cardiologists.

To connect with Dr. Taubel during the event, please reach out to arrange a meeting.

To find out more, click here.

Latest news

Patient safety is not an afterthought. Explore our new infographic!

September 17, 2025
Patient safety is not an afterthought; it is the foundation of every clinical trial.
Read more

Events

JSCPT 2025

5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event